Loading...
Loading...
Among the 4 tracked institutional investors we monitor, PBLS (PARABILIS MEDICINES INC) is held with a combined value of $1.11B across 40,478,053 shares. The largest holder is RA CAPITAL MANAGEMENT, L.P. with a position worth $791.91M (6.88% of their portfolio). 4 funds opened new positions in the most recent quarter.
Total Institutional Value
$1.11B
Total Shares Held
40,478,053
Institutional Holders
4
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
None this quarter.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | $791.91M | 8.39% | New |
| 2 | FMR LLC | $281.71M | 0.01% | New |
| 3 | PRICE T ROWE ASSOCIATES INC /MD/ | $20.58M | 0.00% | New |
| 4 | BAKER BROS. ADVISORS LP | $13.69M | 0.08% | New |
As of the latest SEC 13F filings, RA CAPITAL MANAGEMENT, L.P. is the largest institutional holder of PBLS with a position worth $791.91M, representing 8.39% of their portfolio. In total, 4 institutional investors hold PBLS with a combined value of $1.11B.
In the most recent quarter, 4 funds opened a new position in PBLS.
Institutional investors hold $1.11B worth of PBLS stock across 4 positions. The largest institutional holder is RA CAPITAL MANAGEMENT, L.P. with $791.91M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For PBLS, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their PBLS positions.
| 2026-08-06 |
| 23.8% | 2026-06-18 |
SEC Schedule 13D (activist) and 13G (passive) filings for PBLS. Filed when an investor acquires 5%+ ownership.
Last Close
$39.35
2026-08-18
YTD
+24.5%
100% of 52-week range